We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Self-Help for Dually-Diagnosed Persons - 1

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00218582
First Posted: September 22, 2005
Last Update Posted: January 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Development and Research Institutes, Inc.
Information provided by:
National Institute on Drug Abuse (NIDA)
  Purpose
The purpose of this study is to determine the effectiveness of adding dual focus 12-step self-help groups to standard treatment to improve behavioral outcomes for patients dually diagnosed with substance abuse and psychiatric disorders.

Condition Intervention Phase
Dual Diagnosis Substance-Related Disorders Mental Disorders Behavioral: Double Trouble in Recovery Behavioral: Standard psychiatric day treatment Phase 1 Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effectiveness of Self-Help for Dually-Diagnosed Persons

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • drug/alcohol use [ Time Frame: past 90 days ]

Secondary Outcome Measures:
  • psychiatric medication adherence [ Time Frame: recent ]
  • traditional 12 step meeting attendance [ Time Frame: past 90 days ]
  • psychiatric symptoms [ Time Frame: recent ]
  • program retention [ Time Frame: up to 6 months ]

Enrollment: 229
Study Start Date: March 2003
Study Completion Date: March 2007
Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Dual focus 12 step mutual aid groups for persons with co-occurring disorders (psychiatric and substance use disorders), provided within the context of standard psychiatric day treatment
Behavioral: Double Trouble in Recovery
Dual focus 12 step mutual aid groups for persons with co-occurring disorders (psychiatric and substance use disorders), provided within the context of standard psychiatric day treatment
Active Comparator: 2
Standard psychiatric day treatment
Behavioral: Standard psychiatric day treatment
Individual counseling, groups, medication

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Admission to psychiatric day treatment program 18-64 years old

Exclusion Criteria:

Did not understand or speak English, appeared intoxicated on drugs or alcohol, carried a diagnosis of mental retardation, were deemed actively psychotic by the clinic's intake coordinator, appeared unable to understand and give informed consent.

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00218582


Locations
United States, New York
Albert Einstein Dept of Psychiatry
Bronx, New York, United States, 10461
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
National Development and Research Institutes, Inc.
Investigators
Principal Investigator: Stephen Magura, Ph.D. National Development and Research Institutes, Inc.
  More Information

Publications:
Responsible Party: Stephen Magura, Western Michigan University
ClinicalTrials.gov Identifier: NCT00218582     History of Changes
Other Study ID Numbers: NIDA-15912-1
R01-15912-1
First Submitted: September 20, 2005
First Posted: September 22, 2005
Last Update Posted: January 12, 2017
Last Verified: October 2008

Keywords provided by National Institute on Drug Abuse (NIDA):
12 step groups
self help
psychiatric day treatment
co-occurring disorders
dual diagnosis

Additional relevant MeSH terms:
Disease
Mental Disorders
Psychotic Disorders
Substance-Related Disorders
Pathologic Processes
Schizophrenia Spectrum and Other Psychotic Disorders
Chemically-Induced Disorders